STU3 Candidate

This page is part of the FHIR Specification (v1.8.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationdispense0317.json

Raw JSON (canonical form)

Dispense for Brentuximab Vedotin (NDC code) - IV Chemo - stopped

{
  "resourceType": "MedicationDispense",
  "id": "meddisp0317",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: meddisp0317</p><p><b>contained</b>: </p><p><b>status</b>: stopped</p><p><b>medication</b>: Brentixumab Vedotin (Adcetris). Generated Summary: id: med0306; Adcetris (Brentuximab Vedotin 50mg/10.5ml) <span>(Details : {http://hl7.org/fhir/sid/ndc code '51144-050-01' = '51144-050-01', given as 'Adcetris (Brentuximab Vedotin 50mg/10.5ml)'})</span>; isBrand</p><p><b>patient</b>: <a>Donald Duck </a></p><p><b>dispenser</b>: <a>Rob van den Berk</a></p><p><b>authorizingPrescription</b>: <a>MedicationRequest/medrx0316</a></p><p><b>type</b>: Trial Fill <span>(Details : {http://hl7.org/fhir/ValueSet/v3-ActPharmacySupplyType code 'TF' = 'TF', given as 'Trial Fill'})</span></p><p><b>quantity</b>: 3 415818005<span> (Details: SNOMED CT code 415818005 = '415818005')</span></p><p><b>daysSupply</b>: 1 Day<span> (Details: UCUM code d = 'd')</span></p><p><b>whenPrepared</b>: 25/06/2015 7:13:00 AM</p><p><b>whenHandedOver</b>: 26/06/2015 7:13:00 AM</p><p><b>dosageInstruction</b>: </p></div>"
  },
  "contained": [
    {
      "resourceType": "Medication",
      "id": "med0306",
      "code": {
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/ndc",
            "code": "51144-050-01",
            "display": "Adcetris (Brentuximab Vedotin 50mg/10.5ml)"
          }
        ]
      },
      "isBrand": true,
      "manufacturer": {
        "reference": "Organization/mmanu"
      },
      "product": {
        "form": {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "421637006",
              "display": "Lyophilized powder for injectable solution (qualifier value) "
            }
          ]
        },
        "batch": [
          {
            "lotNumber": "12345",
            "expirationDate": "2019-10-31"
          }
        ]
      }
    }
  ],
  "status": "stopped",
  "medicationReference": {
    "reference": "#med0306",
    "display": "Brentixumab Vedotin (Adcetris)"
  },
  "patient": {
    "reference": "Patient/pat1",
    "display": "Donald Duck "
  },
  "dispenser": {
    "reference": "Practitioner/f006",
    "display": "Rob van den Berk"
  },
  "authorizingPrescription": [
    {
      "reference": "MedicationRequest/medrx0316"
    }
  ],
  "type": {
    "coding": [
      {
        "system": "http://hl7.org/fhir/ValueSet/v3-ActPharmacySupplyType",
        "code": "TF",
        "display": "Trial Fill"
      }
    ]
  },
  "quantity": {
    "value": 3,
    "system": "http://snomed.info/sct",
    "code": "415818005"
  },
  "daysSupply": {
    "value": 1,
    "unit": "Day",
    "system": "http://unitsofmeasure.org",
    "code": "d"
  },
  "whenPrepared": "2015-06-25T07:13:00+05:00",
  "whenHandedOver": "2015-06-26T07:13:00+05:00",
  "dosageInstruction": [
    {
      "sequence": 1,
      "text": "1.8 mg/kg IV infusion over 30 minutes every 3 weeks for 16 cycles",
      "timing": {
        "repeat": {
          "count": 16,
          "frequency": 1,
          "period": 3,
          "periodUnit": "wk"
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "255560000",
            "display": "Intravenous"
          }
        ]
      },
      "doseQuantity": {
        "value": 1.8,
        "unit": "mg/kg",
        "system": "http://unitsofmeasure.org",
        "code": "mg/kg"
      }
    }
  ]
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.